AEAzahara Espartero

Azahara Espartero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Azahara Espartero has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ana I. Raya

    Department of Animal Medicine and Surgery, University of Cordoba, Campus Universitario Rabanales, 14014 Cordoba, Spain

    1 shared publication
  • Angela Vidal

    Department of Animal Medicine and Surgery, University of Cordoba, 14071 Cordoba, Spain

    1 shared publication
  • Carmen Pineda

    Department of Animal Medicine and Surgery, University of Cordoba, Campus Universitario Rabanales, Cordoba, Spain

    1 shared publication
  • Escolastico Aguilera-Tejero

    Department of Animal Medicine and Surgery, University of Cordoba, Campus Universitario Rabanales, Cordoba, Spain

    1 shared publication
  • Ignacio Lopez

    Department Medicina y Cirugia Animal, University of Cordoba, 14071 Cordoba, Spain

    1 shared publication
  • Juan Rafael Muñoz Castañeda

    Research Group: "Calcium Metabolism. Vascular Calcification", Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Córdoba, Reina Sofia University Hospital, Córdoba, Spain; Nephrology Service, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Córdoba, Spain; Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS, RD24/0004/0004), Carlos III Health Institute, Madrid 14 28029, Spain

    1 shared publication

Latest Publications

  • Open Access

    Oral Acid Load Down-Regulates Fibroblast Growth Factor 23

    by Angela Vidal, Carmen Pineda, Ana I. Raya, Rafael Rios, Azahara Espartero, Juan R. Muñoz-Castañeda, Mariano Rodriguez, Escolastico Aguilera-Tejero, Ignacio Lopez

    Increased dietary acid load has a negative impact on health, particularly when renal function is compromised. Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that is elevated during renal failure. The relationship between metabolic acidosis and FGF23 remains unclear. To investigate the effect of dietary acid load on circulating levels of FGF23, rats with normal renal function and with a graded reduction in renal mass (1/2 Nx and 5/6 Nx) received oral NH4Cl for 1 month. Acid intake resulted in a consistent decrease of plasma FGF23 concentrations in all study groups when compared with their non-acidotic control: 239.3 ± 13.5 vs. 295.0 ± 15.8 pg/mL (intact), 346.4 ± 19.7 vs. 522.6 ± 29.3 pg/mL (1/2 Nx) and 988.0 ± 125.5 vs. 2549.4 ± 469.7 pg/mL (5/6 Nx). Acidosis also decreased plasma PTH in all groups, 96.5 ± 22.3 vs. 107.3 ± 19.1 pg/mL, 113.1 ± 17.3 vs. 185.8 ± 22.2 pg/mL and 504.9 ± 75.7 vs. 1255.4 ± 181.1 pg/mL. FGF23 showed a strong positive correlation with PTH (r = 0.877, p < 0.0001) and further studies demonstrated that acidosis did not influence plasma FGF23 concentrations in parathyroidectomized rats, 190.0 ± 31.6 vs. 215 ± 25.6 pg/mL. In conclusion, plasma concentrations of FGF23 are consistently decreased in rats with metabolic acidosis secondary to increased acid intake, both in animals with intact renal function and with decreased renal function. The in vivo effect of metabolic acidosis on FGF23 appears to be related to the simultaneous decrease in PTH.